Item 7.01 Regulation FD Disclosure On February 11, 2016 we issued a news release announcing disclosing that Chief Financial Officer Edward L. Rand, Jr. will assume additional duties as the President of Medmarc, the Company’s life science and legal professional liability insurance subsidiary. Additionally, our news release announced the promotion of Karen M. Murphy, J.D., to Executive Vice-President of Medmarc and Head of Life Sciences for ProAssurance. The changes will be effective March 1, 2016, following the retirement of Medmarc’s long-time president, Mary Todd Peterson. The text of the release is furnished as Exhibit 99.1 to this Current Report on Form 8K. The information we are furnishing under Item 7.01 of this Current Report on Form 8K, including Exhibit 99.1, is not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) as amended, or otherwise subject to the liability of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing. |
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS 99.1 News release issued on February 11, 2016 announcing leadership changes at Medmarc, our life science and legal professional liability insurance subsidiary. |
